Purpura fulminans in an adult patient with Haemophilus influenzae sepsis: Case report and review of the literature

Journal of Burn Care and Research

Volumn 27, Issue 1, 2006, Pages 102-107

  Gast, Thomas ^a   Kowal Vern, Areta ^a,b   An, Gary ^a   Hanumadass, Marella L ^a  

^a Jr Hospital of Cook County   (United States)

^b Sumner L Koch Burn Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA2 GLYCOPROTEIN 1; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PIPERACILLIN PLUS TAZOBACTAM; STEROID; SULFONAMIDE;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CLOTTING DISORDER; CASE REPORT; DISEASE SEVERITY; FEMALE; FULMINATING PURPURA; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; INFECTION; LIMB; MENINGITIS; PHYSIOTHERAPY; RARE DISEASE; SEPSIS; SUPERINFECTION; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; AMPUTATION; ANTI-BACTERIAL AGENTS; BETA 2-GLYCOPROTEIN I; CEFTRIAXONE; FEMALE; GLYCOPROTEINS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; PURPURA, SCHOENLEIN-HENOCH; SEPSIS;

EID: 33745659924     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/01.bcr.0000194269.95027.51     Document Type: Article

References (47)

1. Adcock DM, Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemostas 1990;16:283-92.
2. Spicer TE, Rau JM. Purpura fulminans. Am J Med 1976;61:566-71.
3. Hjort PF, Rapaport SI, Jorgensen I. Purpura fulminans-report of a case successfully treated with heparin and hydrocortisone. Review of 50 cases from the literature. Scand J Haematol 1964;1:169-92.
4. Chasan PE, Hansbrough JF, Cooper ML. Management of cutaneous manifestations of extensive purpura fulminans in a burn unit. J Burn Care Rehabil 1992;13:410-3.
5. Guelloit O. Note sur trios cas de purpura infectieux foudroyant. Un Med Sci Norde-Esr 1884;8:25-9.
6. Henoch E. Ueber purpura fulminans. Prag Med Wochnschr 1886;11:494-9.
7. Chu DZJ, Blaisdell EW. Purpura fulminans. Am J Surg 1982;143:356-62.
8. Warner PM, Kagan RJ, Yakuboff KP, et al. Current management of purpura fulminans. J Burn Care Rehabil 2003;24:119-26.
9. Brown DL, Greenhalgh DG, Warden GD. Purpura fulminans: a disease best managed in a burn center. J Burn Care Rehabil 1998;19:119-23.
10. Seagle BM, Bingham HG. Purpura fulminans. Ann Plast Surg 1988;20:576-81.
11. Childers BJ, Cobanov B. Acute infectious purpura fulminans: a 15-year retrospective review of 28 consecutive cases. Am Surg 2003;69:86-90.
12. Ligier S, Pham CD, Watters AK, Kassis J, Fortin PR. Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease. Scand J Rheumatol 2002;31:371-3.
13. Hollingsworth JH, Mohler DN. Microangiopathic hemolytic anemia caused by purpura fulminans. Ann Intern Med 1968;68:1310-4.
14. Preston FE, Edwards IR. Postpartum purpura fulminans: successful management with streptokinase. Br Med J 1973;3:329-30.
15. Targan SR, Chassin MRG, Guze LB. Dilantin®-induced disseminated intrasvascular coagulation with purpura fulminans. Ann Int Med 1975;83:227-30.
16. Dominey A, Kettler A, Yiannias J, Tschen JA. Purpura fulminans and transient Protein C and S deficiency. Arch Dermatol 1988;24:1442-3.
17. Bick RL, Arbegast NR, Comer TP. Fatal purpura fulminans following cardiopulmonary bypass. J Cardiovascular Surg 1973;14:569-71.
18. Roland FP. Leg gangrene and endotoxin shock due to Vibrio Parahemolyticus - an infection acquired in New England coastal waters. N Engl J Med 1970;282:1306-7.
19. Waddell WB, Saltzman HA, Fuson RL, Harris J. Purpura gangrenosa treated with hyperbaric oxygenation. JAMA 1965;191:99-102.
20. Santamaria JP, Kenney S, Stiles AD. Purpura fulminans associated with Haemophilus Influenzae type b infection. NCMJ 1985;46:516-7.
21. Unal D, Garnier JM, Camboulives J, Viard L. Purpura fulminans: development over a 15-year period. Pediatrie 1986;41:529-36.
22. Dollberg S, Nachum Z, Klar A, et al. Haemophilus Influenzae type b purpura fulminans treated with hyperbaric oxygen. J Infection 1992;25:197-200.
23. Huang DB, Price M, Pokorny J, Gabriel KR, Lynch R, Paletta CE. Reconstructive surgery in children after meningococcal purpura fulminans. J Pediatr Surg 1999;34:595-601.
24. Adderson EE, Byington CL, Spencer LS, et al. Emergence of invasive serotype a Haemophilus Influenzae infections with a virulence genotype resembling H. Influenzae type b: emerging pathogen in the vaccine era? Pediatrics 2001;108:1:e18-e27.
25. Arlukowicz E. Fatal acute purpura fulminans in a child caused by Haemophilus Influenzae: a case report (abstract). J Thromb Haemostas 2003;1(Suppl 1):903_r2339.
26. Krueger M, Fluegge K, Krause MF, Berner R. Fatal Haemophilus influenzas type b sepsis in a 10-month-old infant despite complete vaccination and adequate Hib antibodies. Eur J Pediatr 2004;163:412-3.
27. Krzelj V, Petri N, Mestrovic J, Andric D, Biocic M. Purpura fulminans successfully treated with hyperbaric oxygen - a report of two cases. Pediatr Emergency Care 2005;21:31-4.
28. Rosenthal E, Benderly A, Monies-Chass I, Fishman J, Levy J, Bialik V. Hyperbaric oxygenation in peripheral ischaemic lesions in infancy. Arch Dis Child 1985;60:372-4.
29. Kuzemko JA, Loder RE. Purpura fulminans treated with hyperbaric oxygen. Br Med J 1970;4:157.
30. Dudgeon DL, Kellogg DR, Gilchrist GS, Woolley MM. Purpura fulminans. Arch Surg 1971;103:351-8.
31. Kindwall EP, Goldman RW. Hyperbaric medicine procedures, purpura fulminans (secondary to meningococcus or pneumococcus). Milwaukee, WI: St. Luke's Hospital, 1984. p. 194-5.
32. Waisman D, Shiupak A, Weisz G, Melamed Y. Hyperbaric oxygen therapy in a pediatric patient: the experience of the Israel Naval Medical Institute. Pediatrics 1998;102:E53.
33. Office of Legislative Policy and Analysis. Fiscal 2004 year appropriations. Available at: http://OLPA.od.nih.gov/hearings/108/session1/ testimonies/approp.asp.; Internet; accessed November 1, 2005.
34. Failures after immunization with Haemophilus influenzae Type b vaccines-1991-1995. Canada Communicable Disease Report 1996; 22-23:ISBN 1188-4169: F1-4.
35. Asherson RA, Cervera R. Antiphospholipid antibodies and infections. Ann Rheumatic Dis 2003;62:388-93.
36. Gamba G, Montani N, Moutecucco CM, Caporali R, Ascari E. Purpura fulminans as a clinical manifestation of atypical SLE with antiphospholipid antibodies: a case report. Haematologica 1991;76:426-8.
37. Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as a complicated Henoch-Schonlein purpura. Arch Dis Child 2002;86:132-3.
38. Asherson RA. Infections, antiphospholipid antibodies, and antiphospholipid syndromes. RHEUMA21st. Cutting Edge Reports. published 22 July 2002. Available at: http://www.rheuma21st.com/main.html; Internet; accessed November 1, 2005.
39. Betrosian AP, Balla M, Papanikolaou M, et al. Meningococcal purpura fulminans in a patient with systemic lupus erythematosus: a mimic for catastrophic antiphospholipid antibody syndrome. Am J Med Sci 2004;327:373-5.
40. Rand JH. The antiphospholipid syndrome. Ann Rev Med 2003;54:409-24.
41. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002;90:29-37.
42. Bapat SS, Pulikot AM, Naik P, Chinchankar N. Antiphophoslipid antibody syndrome. Indian Pediatr 2001;38:1413-6.
43. Josephson C, Nuss R, Jacobsosn L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001;50:345-52.
44. McNeil HP, Simpson RJ, Chesterman CN, Krillis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation : β2 glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
45. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
46. Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
47. Sheridan RL, Briggs SE, Remensnyder IP. The bum unit as a resource for the management of acute non-burn conditions in children. J Burn Care Rehabil 1995;16:62-4.